Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 4, 2007, Pages 450-456

  De Jong, Bouke C ^a,b   Hill, P C ^a   Aiken, A ^a   Jeffries, D J ^a   Onipede, A ^a   Small, P M ^c   Adegbola, R A ^a   Corrah, T P ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b STANFORD UNIVERSITY   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Gambia; M. africanum; Mortality; Radiographs; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RADIODIAGNOSIS; SPECIES COMPARISON; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GAMBIA; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 34247171264     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Castets M, Boisvert H, Grumbach G, Brunel M, Rist N. [Tuberculosis bacilli of the African type: preliminary note]. [Article in French]. Rev Tuberc Pneumol (Paris) 1968; 32: 179-184.
2. Kallenius G, Koivula T, Ghebremichael S, et al. Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol 1999; 37: 3872-3878.
3. Mostowy S, Onipede A, Gagneux S, et al. Genomic analysis distinguishes Mycobacterium africanum. J Clin Microbiol 2004; 42: 3594-3599.
4. Marmiesse M, Brodin P, Buchrieser C, et al. Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. Microbiology 2004; 150: 483-496.
5. de Jong B C, Hill P C, Brookes R H, et al. Mycobacterium africanum: a new opportunistic pathogen in HIV infection? AIDS 2005; 19: 1714-1715.
6. Ledru S, Cauchoix B, Yameogo M, et al. Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso. Tubercle Lung Dis 1996; 77: 429-436.
7. de Jong B C, Hill P C, Brookes R H, et al. Mycobacterium africanum elicits an attenuated T-cell response to early secreted antigenic target, 6 kda, in patients with tuberculosis and their household contacts. J Infect Dis 2006; 193: 1279-1286.
8. Caste M, Sarrar H. [Experimental study of the virulence of Mycobacterium africanum (preliminary note)]. Bull Soc Med Afr Noire Lang Fr 1969; 14: 693-696.
9. Kato-Maeda M, Rhee J T, Gingeras T R, et al. Comparing genomes within the species Mycobacterium tuberculosis. Genome Res 2001; 11: 547-554.
10. National Leprosy and Tuberculosis Programme, The Gambia. Annual Report. A S E Kamp, ed. The Hague, The Netherlands: KNCV Tuberculosis Foundation, 2004.
11. Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in South India for tuberculosis prevention. Ind J Med Res 1979; 70: 349-363.
12. Adegbola R A, Hill P, Baldeh I, et al. Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. 2003. Int J Tuberc Lung Dis 2003; 7: 390-393.
13. Heifets L B, Good R B. Current laboratory methods for the diagnosis of tuberculosis. In: B R Bloom, ed. Tuberculosis: protection, pathogenesis, and control. Washington, DC, USA: American Society for Microbiology, 1994: 85.
14. Hill P C, Brookes R H, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38: 966-973.
15. van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
16. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914.
17. van Crevel R, Nelwan R H, de Lenne W, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001; 7: 880-883.
18. Lopez B, Aguilar D, Orozco H, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003; 133: 30-37.
19. Borgdorff M W, Van Deutekom H, De Haas P E, Kremer K, Van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis 2004; 84: 337-340.
20. Malik A N, Godfrey-Faussett P. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis 2005; 5: 174-183.
21. Niobe-Eyangoh S N, Kuaban C, Sorlin P, et al. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol 2003; 41: 2547-2553.
22. Kumar D, Watson J M, Charlett A, Nicholas S, Darbyshire J H. Tuberculosis in England and Wales in 1993: results of a national survey: report of the Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1997; 52: 1060-1067.